Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. - Wikidata - wikimedia - TriplyDB

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

http://www.wikidata.org/entity/Q36756510

about

Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice Short and long-term impact of lipectomy on expression profile of hepatic anabolic genes in rats: a high fat and high cholesterol diet-induced obese model PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats.Intermittent cold exposure enhances fat accumulation in mice.High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice.Inflammation, a link between obesity and cardiovascular disease Adiponectin signaling in the liver Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin.Energy intake and adiponectin gene expression.Adiponectin, a key adipokine in obesity related liver diseases Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes The relationship among adiponectin, high sensitive C reactive protein and triacylglycerol level in healthy young persons.Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.Pilot study on the effects of a 2-week hiking vacation at moderate versus low altitude on plasma parameters of carbohydrate and lipid metabolism in patients with metabolic syndrome.Pathophysiology of diabetic dyslipidaemia: where are we?ADIPOQ single nucleotide polymorphism: Association with adiponectin and lipoproteins levels restricted to men.Adiponectin inhibits lipolysis in mouse adipocytes.Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1.The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions.Adiponectin enhances mouse fetal fat deposition.Epidemiologic evidence on serum adiponectin level and lipid profile.Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis Gut-liver interaction in triglyceride-rich lipoprotein metabolism.Adiponectin and lipoprotein metabolism.Effect of Ziziphus jujube Fruit Infusion on Lipid Profiles, Glycaemic Index and Antioxidant Status in Type 2 Diabetic Patients: A Randomized Controlled Clinical Trial.Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach.Loss of CTRP1 disrupts glucose and lipid homeostasis.Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis.Knockout maternal adiponectin increases fetal growth in mice: potential role for trophoblast IGFBP-1.The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis.Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

P2860

Q27320899-6572DE0E-30EC-4CC4-B8DC-6D597AA92355 Q28543388-312B2BF9-1216-473B-A473-1F44F37011B9 Q30315106-27DB4755-40DE-4D07-85D0-9B5C5AAF8D58 Q30968588-6247E0A8-5D96-44FB-B000-E19D9A61A9E3 Q33560641-BDB3C1F3-8E6E-47FA-BAEE-670C25738FBE Q33616618-1ED352EA-B4F5-4751-B59C-A66CE6C50BD9 Q33642534-7CAE1785-95E5-4A37-8FE0-3F5A251E89F6 Q33688315-89BB5B41-E5A2-4320-A52A-5E6D4C3CAF11 Q33829260-48C6ED58-1750-4B9E-9BD0-EED17085DE81 Q34089724-BB56EA21-3C19-4216-83A6-F237F838BB06 Q34125349-9E635117-AF01-4D41-A953-59F45424E155 Q34492575-1F1FDA3C-1169-43C2-9920-A9F83A8E954F Q34499898-DC1EE31E-AEEB-408E-A682-0B843C908C6B Q34979370-530890BB-9628-431F-BCF9-F5B46C8F5292 Q35061908-A9154281-9FBD-460A-8A5A-FE604C2ABF01 Q35086818-38B21CAD-D681-4F4E-8321-781A1FE2180A Q35140825-6B56EDCE-D145-4D78-AF38-07575AFD68C9 Q35147581-0D9CCB6B-2596-4541-B466-B71CE9ED2629 Q35195082-F365772F-31E8-45AD-A4B7-99AD4C09CC8A Q35248549-6C886097-BFED-44F6-A0DB-98F13DB8163D Q35350326-633B8E0B-17F8-4C6A-AC11-CAE44BAA13E0 Q35794702-B3417230-D845-49FB-8485-83BCA614F2F0 Q35797002-9E69BBC4-154B-435B-990B-84564B3FA024 Q35849950-5105DDAB-1E60-4257-8E9E-B6F9EFB78D3B Q35976593-2766E1E6-2EE2-4485-9CCA-FBAEE4EB38F2 Q36213841-B96BB6DC-3481-40D5-BCDF-BBA1E87E1FC2 Q36294496-D0434FC8-54D5-41B4-82D1-8C2D9474E1C7 Q36410727-009A703A-37B7-4840-B7CC-175A9BB8BFCE Q36706541-4F79D3D1-E97A-4D72-8CBE-A0B93913423B Q36711762-9D42CD5C-DCF6-4966-962C-52EFA78D14F8 Q37073732-A08AB356-2F9A-4D4C-B601-B685D4D44CCE Q37892758-D58112B8-5D83-4D76-811B-334E47DFBC0F Q38129920-E8BF1F6C-FB6C-4559-B189-E7E32FA7625C Q40303200-E951062A-9F58-48AB-ADE4-29DC051B5053 Q40849868-2E7F3788-7160-4E0D-A551-630B3A99E066 Q41630446-F434F733-98E4-4429-89EF-CF204F019D53 Q41867537-7A8E99BC-6AE3-4555-80B9-22E4E9F77AA3 Q42618270-DF72CBE4-99E0-4A30-AF0B-7BB337B18082 Q42956407-B372EAAE-4177-4595-A416-D83C6DAE44CE Q45070271-50E45C6D-6908-4937-BED8-B8BF2ACE56A9

P2860

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

http://www.wikidata.org/entity/Q36756510

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@ast

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@en

type

label

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@ast

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@en

prefLabel

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@ast

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@en

P1433

Q36756510-A36A1CF0-54C7-4AE8-A90A-6B1B825EF478

P1476

Q36756510-96C24839-66C2-4111-87D6-4BD7175541CB

P2093

Q36756510-291301CE-8B90-42A8-8715-A7C3F869BDA8

Q36756510-3DF367A5-D351-4271-8D1B-17C8252EAC09

Q36756510-7BECC338-FCA6-4449-8435-CA60B49B2ABA

Q36756510-B0D13158-B71C-4A49-B8AE-71EC8ED1CC40

P2860

Q36756510-034163CC-22A6-4DB5-9E34-4E18C1CEB8AB

Q36756510-09777557-3DCD-495F-837D-D64BE2028F12

Q36756510-179AF99D-5AE4-4393-82E1-BF38A1708282

Q36756510-1ADB7B96-56DA-4F6A-8D25-C8DC44C71A10

Q36756510-1F4CC6D7-69F0-4C73-8042-525959E150BE

Q36756510-28DC4A85-4D30-4367-92DB-E4B290A935E4

Q36756510-2EC74B30-8256-4986-B295-3E9F6D7742CD

Q36756510-32E4772A-7A56-4C88-AAEB-529EED8DF449

Q36756510-3C38C59E-1B57-414B-AA11-8966D90EA915

Q36756510-3EB3B031-D0AA-4910-AB1D-F13530AF37BE

P304

Q36756510-F390D269-96D7-47AE-8AB8-D6F83648D873

P31

Q36756510-87772D0B-1FF6-4719-9C0E-7601BB22C364

P356

Q36756510-EAE89424-38B9-47EF-B5D2-074DEC8AEB1A

P407

Q36756510-85A84F80-4C5C-4110-BB81-DAF2254645A0

P433

Q36756510-BFF40FDA-DCFA-440A-AE69-192E2F668703

P478

Q36756510-628044F1-FFF3-4348-AE18-00DBA45F6923

P577

Q36756510-C4A2C433-8FDA-4AB1-B16F-E120390BAC64

P5875

Q36756510-68AB7235-6245-4949-B0EA-6FDA86F5FE17

P698

Q36756510-61FBAF6F-0F8A-4BEA-AFAE-3FB8DE98A2E6

P921

Q36756510-C78CE3CC-1FED-4EEA-ACD9-1D776279A793

P932

Q36756510-D085DD54-985B-4B7D-851E-749F2344C83F

P356

P1433

P1476

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

@en

P2093

Chenhui Zou

http://www.w3.org/2001/XMLSchema#string

Deneys R van der Westhuyzen

http://www.w3.org/2001/XMLSchema#string

Jianhua Shao

http://www.w3.org/2001/XMLSchema#string

Liping Qiao

http://www.w3.org/2001/XMLSchema#string

P2860

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity

The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Disruption of adiponectin causes insulin resistance and neointimal formation

C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B

Adiponectin and adiponectin receptors

Living up to a name: the role of the VLDL receptor in lipid metabolism.

The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism.

P304

1824-1833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB07-0435

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5478055

http://www.w3.org/2001/XMLSchema#string

P698

18375436

http://www.w3.org/2001/XMLSchema#string

P921

P932

2453618

http://www.w3.org/2001/XMLSchema#string